It has been reported that NUCB2/nesfatin‐1 could promote cell proliferation, migration and invasion in various cancers including glioblastoma,9 colon,10 endometrial,11 thyroid12 and bladder cancers.13 This evidence concerns the gene NUCB2 and urinary bladder cancer.